Investments
197Portfolio Exits
97Funds
4
Want to inform investors similar to Cormorant Asset Management about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Cormorant Asset Management
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Cormorant Asset Management in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Research containing Cormorant Asset Management
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Cormorant Asset Management in 1 CB Insights research brief, most recently on Aug 5, 2021.
Aug 5, 2021
Here Are The Most Active Healthcare InvestorsLatest Cormorant Asset Management News
Sep 20, 2023
Ambrx Biopharma (NASDAQ: AMAM ) disclosed on Sept. 19 that Cormorant Asset Management purchased 2.15M shares in the company from a period between Sept.15 to 18. The shares were purchased at a price between $9.05- $9.24. Cormorant Asset Management now owns 69.5M shares. Shares in the company up 1.4% at $11.5. Recommended For You
Cormorant Asset Management Investments
197 Investments
Cormorant Asset Management has made 197 investments. Their latest investment was in Star Therapeutics as part of their Series C on September 9, 2023.
Cormorant Asset Management Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/5/2023 | Series C | Star Therapeutics | $90M | No | Agent Capital, Catalio Capital Management, Cormorant Asset Management, Cowen Healthcare Investments, New Leaf Venture Partners, NYBC Ventures, OrbiMed Advisors, Qatar Investment Authority, RA Capital Management, Redmile Group, Sofinnova Ventures, Soleus Capital Management, and Westlake Village BioPartners | 2 |
9/5/2023 | PIPE | Olema Oncology | $130M | No | 3 | |
8/23/2023 | Series B | Rapport Therapeutics | $150M | Yes | 5 | |
8/22/2023 | Series D | |||||
8/9/2023 | Series C |
Date | 9/5/2023 | 9/5/2023 | 8/23/2023 | 8/22/2023 | 8/9/2023 |
|---|---|---|---|---|---|
Round | Series C | PIPE | Series B | Series D | Series C |
Company | Star Therapeutics | Olema Oncology | Rapport Therapeutics | ||
Amount | $90M | $130M | $150M | ||
New? | No | No | Yes | ||
Co-Investors | Agent Capital, Catalio Capital Management, Cormorant Asset Management, Cowen Healthcare Investments, New Leaf Venture Partners, NYBC Ventures, OrbiMed Advisors, Qatar Investment Authority, RA Capital Management, Redmile Group, Sofinnova Ventures, Soleus Capital Management, and Westlake Village BioPartners | ||||
Sources | 2 | 3 | 5 |
Cormorant Asset Management Portfolio Exits
97 Portfolio Exits
Cormorant Asset Management has 97 portfolio exits. Their latest portfolio exit was RayzeBio on September 15, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/15/2023 | IPO | Public | 3 | ||
9/5/2023 | Acquired | 14 | |||
7/18/2023 | Acq - Pending | 2 | |||
Date | 9/15/2023 | 9/5/2023 | 7/18/2023 | ||
|---|---|---|---|---|---|
Exit | IPO | Acquired | Acq - Pending | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 3 | 14 | 2 |
Cormorant Asset Management Fund History
4 Fund Histories
Cormorant Asset Management has 4 funds, including Cormorant Private Healthcare Fund IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
8/4/2021 | Cormorant Private Healthcare Fund IV | $253M | 1 | ||
7/14/2020 | Cormorant Private Healthcare Fund III | ||||
7/14/2020 | Cormorant Private Healthcare Offshore Fund III | ||||
Cormorant Private Healthcare Offshore Fund I LP |
Closing Date | 8/4/2021 | 7/14/2020 | 7/14/2020 | |
|---|---|---|---|---|
Fund | Cormorant Private Healthcare Fund IV | Cormorant Private Healthcare Fund III | Cormorant Private Healthcare Offshore Fund III | Cormorant Private Healthcare Offshore Fund I LP |
Fund Type | ||||
Status | ||||
Amount | $253M | |||
Sources | 1 |
Cormorant Asset Management Team
5 Team Members
Cormorant Asset Management has 5 team members, including current Founder, Chief Executive Officer, Managing Director, Bihua Chen.
Name | Work History | Title | Status |
|---|---|---|---|
Bihua Chen | Founder, Chief Executive Officer, Managing Director | Current | |
Name | Bihua Chen | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Founder, Chief Executive Officer, Managing Director | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
